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Abstract
G protein-coupled receptors (GPCRs) regulate a variety of intracellular pathways through their 
ability to promote the binding of GTP to heterotrimeric G proteins. Regulator of G protein signaling 
(RGS) proteins increase the intrinsic GTPase activity of G-subunits and are widely regarded as 
negative regulators of G protein signaling. Using yeast we demonstrate that GTP hydrolysis is not 
only required for desensitization, but is essential for achieving a high maximal (saturated level) 
response. Thus RGS-mediated GTP hydrolysis acts as both a negative (low stimulation) and 
positive (high stimulation) regulator of signaling. To account for this we generated a new kinetic
model of the G protein cycle where GGTP enters an inactive GTP-bound state following effector 
activation. Furthermore, in vivo and in silico experimentation demonstrates that maximum signaling 
output first increases and then decreases with RGS concentration. This unimodal, non-monotone 
dependence on RGS concentration is novel. Analysis of the kinetic model has revealed a dynamic 
network motif that shows precisely how inclusion of the inactive GTP-bound state for the G
produces this unimodal relationship.
Key words: GPCR; RGS; G protein; computational modeling; signaling
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1. Introduction
Vast numbers of cellular processes are regulated by the GTPase switch, including trans-plasma 
membrane signal transduction, control of cellular growth, vesicle and protein transport and 
cytoskeleton assembly. Increasing the number of GTP-bound G proteins enhances signaling, 
whereas increasing their intrinsic rate of GTP hydrolysis is believed to regulate the pathway 
negatively. Within signal transduction pathways, heterotrimeric G proteins (consisting of a 
nucleotide-binding G-subunit plus Gβ-subunits) couple cell surface-expressed receptors to 
intracellular effectors, in many different cell types. Active G protein-coupled receptors (GPCRs) 
promote nucleotide exchange on the G-subunit, causing dissociation of the heterotrimer and 
subsequent effector activation [1,2]. Regulator of G protein signaling (RGS) proteins accelerate 
GTPase activity of the G-subunit (by acting as GTPase activating proteins; GAPs) thereby 
reducing production of second messengers from the effector [3,4].
The pheromone-response pathway in yeast provides a model G protein-coupled signal 
transduction pathway that controls cell conjugation and division [5]. The binding of pheromones to 
receptors activates an effector system via the heterotrimeric G protein, to initiate intracellular 
changes that regulate the transcription of mating genes [6,7]. Yeast is therefore free from the 
complication of multiple receptors, effectors and other regulatory proteins [7]. RGS proteins were 
originally described in Saccharomyces cerevisiae as negative regulators of the pheromone-response 
pathway, where they minimize spontaneous cell activation and enable cells to recover from 
stimulation in the absence of conjugation [8]. In Sc. cerevisiae, Gβ-subunits stimulate effector 
activation, potentially making this pathway less affected by proteins that influence nucleotide 
hydrolysis on the G-subunit [9]. In contrast the fission yeast Schizosaccharomyces pombe, utilized 
the G-subunit of a classical heterotrimeric G protein, Gpa1, as its signal propagator of the 
pheromone-response pathway [10-12]. Briefly Sz. pombe cells, during their mating cycle, grow up a 
pheromone gradient produced by a cell of the opposite mating type. The pheromones, (P-factor or 
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M-factor) upon detection by mating type specific GPCRs, activates Gpa1 which propagates the 
signal by promoting the activation of Ras1. This leads to stimulation of a mitogen-activated protein 
kinase (MAPK) cascade resulting in the activation of the transcription factor Ste11 [6,9]. In addition 
to the transcription of pheromone-dependent genes, Sz. pombe also undergoes a morphological 
change in response to pheromone. Responding cells continue to grow from the tip of the cell and 
elongate towards the source of the pheromone forming a shmoo [13]. It currently remains unknown 
how Gpa1 activates both pathways.
Deletion of rgs1 in Sz. pombe increases ligand-independent signaling and reduces mating 
efficiency [14-16], which suggests that Rgs1 acts as a negative regulator of the pheromone-response 
as reported in Sc. cerevisiae [7]. Here we demonstrate that at high ligand concentrations, Rgs1 also 
plays a positive role in regulating the pheromone-response. Through targeted mutational analysis, 
we alter the GTPase activity on Gpa1 to demonstrate that GTP-hydrolysis is absolutely required to 
achieve maximum signaling.
A mathematical model has been developed that reproduces in vivo data, and provides a 
novel mechanistic description of the G protein signaling pathway. Crucial to the faithful 
reproduction of the observed phenomena is the assumption that one GGTP activates only one 
effector molecule per round of guanosine nucleotide exchange and hydrolysis. Entry into an 
inactive but GTP-bound state following the activation of an effector removes the GGTP from the 
pool of molecules available for signaling, rather than allowing further effector activation by the 
same molecule. GTP hydrolysis, accelerated by an RGS protein, releases the G from this inactive 
GTP-bound state and allows subsequent reactivation by ligand-bound receptors and then activation 
of another effector molecule. Parallel in vivo and in silico experiments reveal a non-monotone 
relationship with a single maximum (i.e. unimodal) between pathway output and quantity of RGS 
protein. This non-monotone relationship reflects the dual positive/negative character of RGS 
regulation. An abstract dynamic network motif that captures the underlying structure of the more 
complex mathematical model is used to derive the non-monotone relationship explicitly. Finally, 
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comparison of this motif with an alternative motif, whose structure underlies many current models 
of G protein signaling, shows why these current models are unable to account for non-monotone
regulation by the RGS.
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2. Materials and methods
2.1 Strains, reagents and general methods
The effector output from the pheromone-response pathway in Sz. pombe can be quantified using 
pheromone-dependent transcription of -galactosidase expressed from the sxa2>lacZ reporter 
construct as described previously [16,17]. All yeast strains (Supplementary table S9) have been 
described previously [12,16] with the exception of JY1340 which was derived from JY546 but had 
gpa1 replaced with gpa1G223S. Gene replacements were confirmed by polymerase chain reaction 
(PCR) and Southern blot analysis. General yeast procedures were performed as described [18,19]. 
Oligonucleotides were synthesized by Invitrogen Ltd. (Paisley, Scotland, UK). Amplification by 
PCR used Pwo DNA polymerase (Boehringer Mannheim Biochemicals, Lewes, UK) or KOD HiFi 
DNA polymerase (Merck Chemicals Ltd., Nottingham, UK). All constructs generated by PCR were 
sequenced.
2.2 Assay of -galactosidase activity
-galactosidase assays in Sz. pombe cells were performed as described previously [16,20]. Sz. 
pombe cells were cultured to a density of ~5 x 105 cells ml-1 in DMM and 500 l aliquots 
transferred to 2-ml Safe-Lock tubes (Eppendorf, Hamburg, Germany) containing 5 l of P-factor (in 
HPLC-grade methanol). Tubes were incubated at 29˚C for 16 h on a rotating wheel, and 50 l 
transferred to 750 l Z-buffer containing 2.25 mM o-nitrophenyl--D-galactopyranoside (ONPG). 
Reactions were stopped after 90 min by adding 200 l of 2 M Na2CO3 and -galactosidase activity 
calculated as optical density at 420 nm (OD420) per 10
6 cells (determined using the Z2 Coulter 
Channelyzer) (Beckman Coulter, Luton, UK).
2.3 Plasmids
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pREP3x contains the LEU2 gene and pREP4x contains the ura4 gene, both of which were 
controlled by thiamine-repressible nmt1 promoter [21]. The production of all Gpa1 constructs with 
the exception of Gpa1Q244L, have been described [12]. Gpa1Q244L was generated by bipartite PCR 
[22] on the wild type constructs. Generation of pREP3x-Rgs1 and pREP4x-Rgs1 was described 
previously [12]. Mutant Rgs1 constructs were generated by inverse PCR on wild type rgs1. GFP 
constructs were made using a two-step cloning technique described previously [17].
2.4 Model simulations
A chemical kinetic model, based upon the reaction scheme shown in Fig. 3, using a system of ODE 
was solved using the xCellerator (California Institute of Technology, Pasadena, CA) add-on 
package for Mathematica v5.0 (Wolfram Research Inc, Champaign, IL). Experimental strains were 
simulated by altering the relevant reaction rate constants and initial conditions (Supplemental Table 
S3). Data were analyzed using linear and non-linear regression as appropriate using GraphPad 
Prism v4.03 (GraphPad Software Inc, San Diego, CA).
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
8
3. Results
3.1 GTP hydrolysis is essential for maximal signaling in a GPCR-stimulated pathway
Previous studies have indicated that Rgs1 is essential for mating in Sz. pombe [14-16]. Utilizing 
modified yeast strains where the pheromone-inducible gene sxa2 has been replaced with bacterial 
LacZ gene [16] we demonstrate that unstimulated cells, deleted for rgs1 (Rgs1 in Fig. 1A), display
a 4-fold increase in signaling compared to cells expressing Rgs1 (Fig. 1A) (deletion of rgs1 does 
not affect receptor or G protein expression; data not shown). Further, rgs1 deletion also increases 
yeast’s sensitivity to pheromone stimulation (pEC50; Rgs1 = 6.8  0.05, Rgs1 = 8.3  0.1). These 
results are consistent with the notion that RGS proteins act as negative regulators of signaling. 
However, when stimulated with pheromone concentrations 1 M, rgs1 cells show a ~2-fold 
increase above ligand-independent levels, compared to a ~15-fold increase for cells expressing wild 
type Rgs1. The absolute level of signaling at saturating pheromone concentrations is therefore much 
higher in cells containing Rgs1 than those lacking it. This suggests that the effects of Rgs1 on the G 
protein-coupled pheromone-response pathway vary with ligand concentration. In the absence of 
pheromone, or at low pheromone concentrations, Rgs1 suppresses Gpa1 signaling. However, at 
higher ligand concentrations, the presence of Rgs1 facilitates increased effector output and therefore 
potentiates signaling through the pathway. To date, RGS proteins are most often reported as 
negative regulators of signaling [3,4]. Thus the observation presented here that RGS proteins 
increase the maximal capacity of a pathway, represents a novel role for these proteins.
The interaction of RGS proteins with a G-subunit can be blocked by mutating a conserved 
glycine to serine [23], which in Gpa1 corresponds to glycine 223 [12]. We directly replaced the 
wild type chromosomal copy of Gpa1 with Gpa1G223S. Cells expressing Gpa1G223S exhibit a 
phenotype almost identical to a rgs1 strain containing wild type Gpa1 (Fig. 1A). Expression of the 
Gpa1G223S from a plasmid resulted in an attenuated pheromone-response similar to that observed 
when expressed chromosomally (Fig. 1B). By comparison, expression of Gpa1 from a plasmid in 
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strains where the chromosomal copy of gpa1 had been deleted resulted in normal pheromone 
sensitivity and responsiveness (compare Fig. 1B with Fig. 1A). 
The GTPase activity of the G-subunit of heterotrimeric G proteins can be manipulated by 
mutating critical residues in the switch region II [24,25]. Versions of Gpa1 were expressed from 
plasmids (which give equivalent expression levels to chromosomally integrated versions [12]) in 
strains where the chromosomal copy of gpa1 had been deleted (Fig. 1B), with and without deletion 
of chromosomal rgs1 (Fig. 1C). Mutation of glutamine 244 (to leucine) generated a GTPase 
deficient Gpa1 [8,10,23]. This mutation displayed constitutive activity, increased pheromone 
sensitivity (pEC50; pGpa1 = 6.775  0.046, pGpa1Q244L = 7.209  0.3) and a level of maximal 
signaling approximately half that of wild type levels. Deletion of chromosomal rgs1 reduced 
signaling in strains expressing plasmid-borne wild type Gpa1 but had no additional effect on the 
GTPase deficient mutant (Fig. 1C). Therefore the GTPase activity of Gpa1 is essential for cells to 
achieve maximal pheromone-induced signal transduction.
In strains where rgs1 had been deleted, over-expression of Gpa1 increased both ligand-
independent and maximal signaling (at pheromone concentration  1M; Fig. 1D) and increased 
ligand sensitivity. Expression of an additional copy of Gpa1 also increased maximal signaling in the 
presence of Rgs1. Taken together these data demonstrate that the decrease in maximal signaling 
observed in the absence of Rgs1 is due to a reduction in the effective concentration of G-subunits 
available for GPCR activation. Thus, we suggest that maximal effector activation requires Rgs1-
catalyzed increases in GTP hydrolysis by the G-subunit.
3.2 Deletion of Rgs1 reduces the duration of the response
A reduction in the cells ability to hydrolyze GTP upon Gpa1 results in an attenuated maximal 
pheromone induced signaling response while previous observations have indicated that Sz. pombe
strains deleted for Rgs1 display a reduced mating efficiency [14,15]. We hypothesized that the 
attenuation of maximal signaling, coupled to reduced mating efficiency might result from a loss of 
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the cells ability to temporally detect changes in the pheromone gradient. Thus, cells containing or 
lacking Rgs1 were compared of their time- and dose-dependent signaling characteristics over a 16 h 
time-frame [16]. For cells expressing Rgs1, -galactosidase was detectable at times consistent with 
sxa2 expression (observed after 4 h) reaching a plateau after 10 h [16]. This was in contrast to the 
profiles observed for cells deleted for Rgs1 which displayed increased ligand-independent signaling 
(Fig. 2) and appeared to achieve their maximal level of signaling after 4-6 h post simulation (Fig.
2C). In addition, similar observations were achieved for strains expressing Gpa1G223S and Gpa1Q244L
(data not shown). These results suggest that the deletion of Rgs1 reduces maximal signaling by 
attenuating the duration of the response and is consistent with the notion that there is a reduction in 
the effective concentration of active Gα subunits. We suggest, based upon the data shown in Figures 
1 and 2, that the Gα-GTP becomes blocked in an inactive state once it has encountered an effector 
molecule.
3.3 Modeling of the GTPase cycle
The observation that RGS activity has a positive effect on GPCR signaling contradicts the 
consensus that these proteins function as negative regulators [3,4]. Therefore the existing reaction 
schemes describing receptor-stimulated GTPase cycles, including those generated in yeast, could 
not be used to simulate our observations (see [26-32] and Supplementary text. We therefore 
formulated a new mechanistic hypothesis for the GTPase cycle that allows RGS proteins to act as 
both negative and positive regulators of effector output. This is presented as a reaction scheme in 
the Supplementary table S1) and shown schematically in Fig. 3. The reaction scheme is based upon 
the currently identified components within Sz. pombe that regulate the G-mediated pheromone 
response.
We suggest that at low concentrations of ligand-bound receptor (LR), when only small 
amounts of GGTP are generated, the RGS protein increases the rate of GTP hydrolysis, 
significantly limits effector activation (parameter k7 in Fig. 3) which is acting as a negative 
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regulator of signaling. Consequently, removing the RGS protein allows more GGTP to encounter 
and activate effectors (parameter k10). At high ligand concentrations, a much larger proportion of 
the total pool of GGDP is converted to GGTP by the stimulated receptor, overwhelming the 
negative regulatory role of the RGS proteins which enables the effector system to become activated 
despite the presence of the RGS. Up to this point the mechanism is in broad agreement with 
published schemes [26-32]. Achieving the positive effect of RGS activity necessitated the inclusion 
of a second term for a GTP-bound G-subunit (ĜGTP) specifically generated following an 
encounter with an effector; this constitutes a “post-signaling” state for the G protein. We suggest 
that ĜGTP takes no further part in signaling until it has hydrolyzed its GTP in a reaction that can be 
accelerated by the RGS protein. At high levels of ligand stimulation, when the rate of guanine-
nucleotide exchange has become greater than the rate of pre-signaling hydrolysis, signal 
amplification is, in effect, subject to a positive feedback loop. This arises because both pre-
signaling GGTP and post-signaling ĜGTP compete for the RGS. Consequently, the amount of free 
GGTP is increased because the negative role (pre-signaling hydrolysis) is reduced and the positive 
role (turnover of post signaling ĜGTP) is accelerated. 
3.4 Using mathematical modeling to characterize the novel GTPase cycle
Mathematical and computational modeling has a long history in the GPCR field and offers a 
powerful tool for testing alternative hypothesis relating to the GTPase cycle. Such models can be 
used to understand conflicting hypotheses, run virtual experiments and offer new explanations for 
observed phenomena [33]. We therefore performed in silico simulations based upon a system of 
ordinary differential equations (ODEs) that describe the reaction scheme presented in Fig. 3 (see 
Supplementary text, tables, figures and equations). The pathway was modeled empirically and 
tested to determine its ability to provide sufficient regulatory flexibility to reproduce the in vivo data. 
Due to incomplete quantitative data for all rate constants and species concentrations, strong 
qualitative agreement between simulations and in vivo data was desired. Parameter values were 
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hand-tuned to fit with in vivo experimental data. The cellular concentration for the GPCR – Mam2 
has been determined to be 205 nM [17]. Although the precise Gpa1 concentration remains to be 
determined in Sz. pombe, as in many other published models [26-32], we have used a ratio of 1:1 
for GPCR concentration to G concentration. Our concentration of the RGS species was estimated 
to be 4-fold lower than the Gpa1/Mam2 concentration (60 nM) and is in agreement with that 
observed for other RGS proteins [27,30,32,34]. All reactions were assumed to occur with net 
forward direction using mass action kinetics similar to several models of G protein mediated 
signaling pathways [27,28,32]. To enable simplicity of or modeling, we have included more detail 
about the G protein activation/deactivation cycle than the downstream MAP kinase cascade. Our 
choice of parameters is based upon the response kinetics that we observed in the time course assay 
shown in Fig. 2. Our in vivo response is measured by detecting the accumulation of β-galactosidase. 
We simulated this by determining the integral of the number of active effector molecules 
(GαGTPEffector) after applying a cascade of linear relaxation elements (Supplemental text). A 
detailed parameter sensitivity analysis will be published elsewhere.
While our model may not contain all possible reactions as such could be described as rather 
‘simple’, it was able to reproduce the observed biological responses for both the time- and dose-
dependent effects of an agonist on an effector system in the presence or absences of RGS activity 
(compare Fig. 4 to Fig. 2; a comparison of pEC50 values is shown in the Supplementary table S8). 
We simulated the effect of altering G protein activity and concentration in the model in the presence 
and absence of a functional RGS activity. An RGS-insensitive version of the G protein, equivalent 
to mutating glycine 223 in Gpa1, was generated within the model by preventing the association of 
RGS with the G protein both before and after effector interaction (parameters k7 and k12 reduced to 
zero). Output from the model containing an RGS-insensitive G protein behaved the same as when 
RGS was deleted from the model, thus reproducing the in vivo data (compare Fig. 5A to Fig. 1A). 
Both in the presence or absence of an RGS, parameters controlling GTPase activity were set to zero 
(parameters k8, k9, k13 and k14), generating the equivalent of a GTPase deficient G protein. Here too, 
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output from the model accurately reproduced the effect of in vivo mutation of glutamine 244 to 
leucine (compare Fig. 5B and 5C with Fig. 1B and 1C). To simulate over-expression of Gpa1, the 
concentration of G was doubled within the model in the presence and absence of RGS activity. 
Again the model was able to accurately reproduce our in vivo data (compare Fig. 5D with Fig. 1D). 
The model qualitatively simulates the effects of altering G protein activity and availability within 
the pathway, as well as predicting the dual roles of RGS activity in regulating GPCR signal 
transduction.
In some GPCR signaling systems, for example the pheromone-response pathway in Sc.
cerevisiae, the G, rather than the GGTP, propagates downstream signaling [7]. We investigated 
whether our modified computational model was able to simulated G-mediated pathways.
Conversion of the signal propagator from GGTP to G, in the presence of RGS activity, preserved 
the shape of the ligand-response profile whilst total effector output increased 6-fold (compare Fig.
5A with Fig. 5E). Removal of RGS activity resulted in increases in ligand-independent signaling, 
ligand-dependent responsiveness (pEC50; RGS = 7.3 ± 0.023, ΔRGS = 6.6 ± 0.021) and maximal 
effector output (Fig. 5E). Within this modified model, setting the parameters controlling GTPase 
activity to zero (mimicking a GTPase deficient G subunit) generated an effector output profile 
almost identical to that obtained when RGS activity was removed (Fig. 5E). So in systems of this
kind, RGS proteins appear only able to negatively regulate signaling.
3.5 Maximal effector output requires RGS-dependent recycling of GGTP
In a system with GGTP as a signal propagator the amount of intracellular GGTP produced is clearly
critical to controlling output. Since RGS proteins accelerate hydrolysis and hence regulate the 
amount of free GGTP available, the system should be profoundly sensitive to their concentration. 
Simulating a doubling (120 nM) or trebling (180 nM) of RGS concentration within the model (Fig.
6A), reduced the sensitivity of the system to ligand such that the predicted EC50 value for ligand-
stimulated effector activation was reduced by 4-fold and 8-fold respectively. This effect of 
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increased RGS concentration on sensitivity to ligand stimulation is consistent with the widely 
accepted role of RGS proteins as negative regulators of signaling. On the other hand, the novel 
positive role played by RGS proteins within the signaling pathway is further evident from the 1.5-
fold increase in maximal effector output when the RGS concentration is doubled from 60 nM to 120 
nM. The model predicts that with further increase in RGS concentration, to 180 nM, maximal 
effector output is reduced to half that occurring at 60 nM, putting it at a level similar to that 
produced when the RGS is removed. Thus, for obtaining high maximum output, an RGS 
concentration of 120 nM is optimal according to the model simulations.
To test the predictions of doubling the RGS concentration in yeast, the endogenous Rgs1 
concentration expressed from the chromosomal copy of the gene was increased by introduction of a 
plasmid-borne copy of the gene. To increase the Rgs1 concentration further an additional plasmid 
was used to express a third copy of the gene so trebling the RGS concentration. Expression of Rgs1-
green fluorescent protein (GFP) from one or two different plasmids together with chromosomal 
expression demonstrated that fluorescence increased linearly with increased protein expression 
(data not shown). Chromosomal and plasmid derived copies of Rgs1 exhibited equivalent effects 
upon pheromone signaling (see Supplemental Fig. S4). The results in Fig. 6B show that an increase 
in Rgs1 concentration, generated by the addition of a plasmid expressing Rgs1, in the yeast 
increased maximum effector output (1.6-fold) and reduced sensitivity in response to pheromone 
(pEC50; 1xRgs1 = 6.88  0.05, 2xRgs1 = 6.08  0.05), in agreement with predictions from the 
computational model. Importantly, increasing the Rgs1 intracellular concentration by approximately 
3-times reduced pheromone sensitivity by 10-fold when compared to 1xRgs1 (pEC50; 3xRgs1 = 
5.85  0.1) and, as predicted by the model, also attenuated maximal effector output. These data 
demonstrate that the dual role for Rgs1 within the signal transduction pathway is concentration-
dependent.
The data in Fig. 6A and 6B suggest a non-monotone relationship between the signaling 
output and the RGS concentration. To investigate this relationship in more detail, a simulation of 
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signaling output against RGS concentration between 0 nM and 200 nM was plotted for a number of 
ligand concentrations (Fig. 6C). In the absence of stimulation or at low levels of ligand (1-10 nM), 
modest increases in RGS concentration (0-30 nM) rapidly abolishes effector output. However, at 
higher concentrations of ligand (>100 nM), increased RGS concentration acted positively to 
enhance signaling until a maximum was reached where the negative inhibitory effects again 
predominated. Similar analysis of the in vivo data (Fig. 6D), shows agreement with the in silico
predictions Fig. 6C. It is interesting to note when RGS concentration reaches 180 nM (3-times 
endogenous levels) the negative role of the RGS activity dominates at all ligand concentrations. We 
suggest that the transition between the positive and negative roles of RGS activity within the GPCR 
pathway appears to be dependent on both the concentration of RGS and the concentration of GGTP
generated by ligand-bound-receptors. 
3.6 A dynamic network motif
To determine precisely how complex signaling networks function, it is often useful to identify the 
simplest network structure or motif [35]. Such motifs allow us to explicitly determine the system’s 
dependence on the parameters and the effects of perturbations on its output. Furthermore, analysis 
of the structure of different models facilitates comparison between competing hypotheses. 
A network motif was identified (Fig. 7A) that captures the underlying structure of the more 
complex model of the G protein GTPase cycle presented in this paper. The network has both a pre-
signaling state (X[1], analogous to GGTP) and a post-signaling state (X[2], analogous to ĜGTP) for 
the signaling molecule (X) both of which can be bound by the regulatory molecule (R, analogous to
the RGS protein). Subsequent to formation of the complexes R[1] and R[2], the signaling molecule is 
converted back to its basal state (X°) and free regulatory molecule (R°) is released. Fig. 7B 
demonstrates that this motif produces the non-monotone relationship, as found experimentally,
between maximum steady state output flux and quantity of regulatory molecule at maximum 
stimulation. By contrast, a network motif (Fig. 7C) that possesses no post-signaling state, abstracted 
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from existing models [26-32], produces a relationship between maximum steady state output flux 
that is a monotone decreasing function of the amount of regulatory molecule (Fig. 7D). Thus, a 
network motif lacking a post-signaling state is unable to account for the non-monotone behavior 
shown in Fig. 6. 
The explicit relationships produced through the mathematical analysis (detailed in the 
Supplementary text) of the network motifs are largely insensitive to parameter values (rate 
constants must only be real and positive). Thus we confirm, in a parameter-independent way, that it 
is the addition of a post-signaling state that also may be bound by the regulatory molecule, which 
endows the system with the observed dynamical properties. 
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4. Discussion
4.1 GTP hydrolysis is essential for maximal signaling in Sz. pombe
Analysis of a GPCR pathway in the yeast Sz. pombe demonstrates that GTP hydrolysis of the G, 
rather than retention of a GTP-bound state, is essential for maximal response to pheromone. Thus 
GGTP cannot continually activate effectors and we suggest that one G activates one effector per 
GTP hydrolysis event. Consequently RGS proteins (that act as GAPs for GGTP) can act as positive 
regulators of signaling by accelerating conversion of GGTP to GGDP and returning the inactive 
G-subunits to ligand-occupied receptors, enabling their reactivation. Our conclusions are derived 
from three key observations. First, at high levels of stimulation, the GTPase-enhancing activity of 
Rgs1 was required to maximize effector output (Fig. 1A, Fig. 2 and Fig. 6D). Secondly, the use of a 
GTPase-deficient mutant of Gpa1 (Gpa1Q244L) demonstrated that GTP hydrolysis is essential for 
maximal signaling (Fig. 1B and 1C). Thirdly, increasing the intracellular Gpa1 concentration 
increased effector output in the presence or absence of Rgs1 (Fig. 1D). From this we infer that 
removal of the RGS protein reduces effector output by decreasing the supply of GGDP available to 
be re-activated by ligand-occupied GPCRs. Since in the absence of RGS activity, the intrinsic rate 
of GTP hydrolysis by G-subunits is slow, we propose that G-subunits attain a post-signaling 
GTP-bound conformation following their encounter with an effector (which we denote ĜGTP). 
Only by the hydrolysis of the bound nucleotide, in a reaction that is significantly enhanced by an 
RGS protein, can ĜGTP be returned to the pool of G subunits available for subsequent receptor 
activation. A reaction scheme revised to incorporate this new hypothesis (Fig. 3) encompasses a 
second GTP-bound state for G from which GTP hydrolysis is the only possible exit. Model 
simulations were in broad agreement with experimental data, whereas other models tested (based on 
[26-32], as well as several of our own competing hypotheses; see Supplementary text) failed to 
adequately describe the same data. The agreement between model and experiment strongly suggests 
that an RGS protein can both positively and negatively regulate G protein signaling and achieves 
this through its GTPase-accelerating activity.
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Further evidence for the existence of post-GTP hydrolysis conformational states capable of 
regulating effectors, has been provided by the use of G-subunit mutants which trapped 
intermediates within the G protein cycle [36]. The possibility that G proteins can enter alternative 
GTP-bound states has been further raised by the existence of a tetra-co-coordinated transition state
(G‡GTP) in the hydrolytic mechanism (reviewed [3]). This intermediate may be mimicked 
experimentally through the use of AlF4
- binding to GGDP [36] although it remains to be determined 
if ĜGTP resembles G‡GTP or GGDP·AlF4-. It is of paramount importance that we now 
biochemically prove the existence of our ĜGTP both in vivo and in vitro. Finally, our suggestion
that one G activates one effector per GTP hydrolysis event has been proposed for the activation of 
phospholipase C (PLC) by mammalian Gq. In addition to its role as an effector, PLC functions as 
a GAP for Gq-GTP promoting its conversion back to the inactive GDP-bound state [37]. 
Our reaction scheme is based upon the current components established to regulate 
pheromone signaling. To date there are no reports of scaffolding proteins known to interact with the 
receptor or the RGS protein in Sz. pombe. Other scaffolding proteins in yeast have been identified 
within the MAPK cascade (e.g. STE5 in Sc. cerevisiae) although they do not appear to perform any 
roles in the activation of the G proteins by pheromone-occupied receptors [38]. Further, within 
yeast, the existence of proteins such as the arrestins (molecules known to modulate GPCR activity 
in mammalian cells) has not been documented. Recently, in Sc. cerevisiae it has been demonstrated 
for that SST2 interacts with the C-terminal tail of STE2 (the -factor receptor). It is suggested that 
this interaction places the SST2 in close proximity to the activated G subunit hence enabling rapid 
hydrolysis of the GTP associated with any activated G-GTP terminating the response [39]. In Sz. 
pombe a similar interaction between Rgs1 and Mam2 (the P-factor receptor) which could 
antagonize low level-ligand stimulation, while enabling rapid recycling of G subunits at high 
ligand concentrations. While as yet there is no direct evidence of a physical interaction between 
Mam2 and Rgs1, it is worth noting that, deletion of the C-terminal tail from Mam2 increases 
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ligand-independent signaling, and reduces the maximal response consistent with a reduction in 
Rgs1 activity (Hill et al., in preparation).
Detailed investigation of the model predicted a non-monotone relationship between the 
concentration of RGS and output from the pathway. This result was validated by subsequent in vivo
experiments where the concentration of RGS expressed in cells was manipulated via plasmid-borne 
expression of the Sz. pombe RGS protein, Rgs1. In order to explain this relationship and to explore 
the functional consequences of the existence of a post-signaling state for the G, we developed a 
novel dynamic network motif that captures the underlying structure of the more complex model. 
This simple structural unit displays all the critical characteristics of the more complex pathway. A 
similar abstract motif, which captures the underlying structure of most published models of the G 
protein GTPase cycle, demonstrated that it could not reproduce the non-monotone relationship 
between maximum output and concentration of RGS. This qualitative behavior is not dependent on 
the parameter values, alleviating the need for an extensive parameter search on the more detailed 
kinetic model. 
4.2 Biological implications
Evidence is emerging to suggest that RGS proteins can play positive roles in GPCR signaling [40]. 
They have been reported to accelerate the activation kinetics of G protein-gated potassium channels 
(GIRK), Ca2+ channels [41-45] and on synaptic transmission [26]. Although the mechanisms within 
those pathways are not fully understood, some of them may operate mechanistically according to 
the novel general motif presented in this manuscript.
Modifying the mathematical model so that it simulates a system in which the G and not 
the GGTP propagates downstream signaling, results in the RGS acting solely as a negative regulator.
Interestingly, this modification makes the system analogous to that of the pheromone-response 
pathway in Sc. cerevisiae in which the prototypical RGS protein (SST2) was originally described as 
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a negative regulator [27,46-48]. This suggests the GTPase cycle hypothesis presented here is also 
compatible with current understanding of G-mediated signaling pathways.
The pheromone-response pathway that governs Sz. pombe mating requires the cells to enter 
a cell cycle arrest and undergo a change in polarity and extend towards the source of the pheromone 
(i.e. a mating partner). Therefore, there is an advantage in responding rapidly to a cell that secretes 
the highest ligand concentration and we suggest that Rgs1 helps to confer this chemotropic 
advantage. First, Rgs1 narrows the range of effective pheromone concentration by at least one order 
of magnitude (Fig. 1 and 2). Secondly, Rgs1 serves to reduce the sensitivity of the system thereby 
raising the threshold concentration at which the cell will respond. Finally, Rgs1 increases the 
magnitude of the response at levels of stimulation above the threshold. Similar suggestions have 
been proposed for the Sc. cerevisiae, where deletion of SST2 appears to cause defects in the cells 
ability to sense and respond to a pheromone gradient [34].
A non-monotone, unimodal relationship between RGS concentration and maximum signal 
transmission allows the cell to dynamically adjust and fine-tune the sensitivity and size of response 
by altering RGS expression levels. Moreover, if RGS expression is driven by the output of the 
pathway itself, a feedback loop results that allows the system to adapt to average levels of 
stimulation and become responsive only to sudden upward deflections in the signal. This would 
allow the yeast cell to respond to the proximity of another cell, regardless of the general background 
levels of pheromone encountered in its environment. 
Our observations have been made in a GPCR signaling cascade and suggest that GTP-
dependent switches can be more complex than simply G proteinGDP
(inactive) and G proteinGTP
(active). It
remains to be determined if this hypothesis can be applied to small monomeric GTP binding 
proteins as well.
5. Conclusions
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GPCRs couple to various intracellular signaling pathways via heterotrimeric G proteins that 
cycle between GTP and GDP-bound conformations. RGS proteins increase the intrinsic GTPase 
activity of G subunits and are widely regarded as negative regulators of G protein signaling. Using 
the pheromone-response pathway in Sz. pombe as a model G protein-coupled receptor system, we 
show that abolition of RGS-accelerated GTP hydrolysis reduces the cell’s response to maximal 
stimulation. To explain how RGS proteins act as positive regulators of signaling, a combination of 
biochemical, genetic and computational approaches has generated a new kinetic model of the G 
protein cycle. Our results indicate that RGS proteins enhance signaling through their ability to 
accelerate GTP hydrolysis on G subunits that have encountered an effector thereby increasing the 
supply of G-GDP that can be activated by GPCRs. Further, by abstracting our computational 
model of the G protein cycle we have identified a novel network motif that explains how our model 
can account for the dual role of GTP hydrolysis. Our demonstration that RGS proteins function as 
both negative and positive regulators of GPCR signaling has revealed a new perspective on the G 
protein cycle in which one G-GTP activates one effector molecule.
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Figure legends
Fig. 1
Mutating residues essential for G-mediated GTP hydrolysis reduces maximal pheromone 
signaling independent RGS activity. Pheromone-dependent transcription of -galactosidase 
expressed from the sxa2>lacZ reporter construct was measured in yeast strains; (A) expressing wild 
type Rgs1 (■), a chromosomally expressed RGS-insensitive form of Gpa1 (Gpa1G223S; ) or 
deleted for Rgs1 (ΔRgs1; □), (B) deleted for the chromosomal copy of gpa1 (JY1285) and 
expressing wild type (■), an RGS-insensitive (Gpa1G223S; ) or GTPase deficient (Gpa1Q244L, ▲) 
form of Gpa1 from a plasmid, (C) deleted for the chromosomal copies of both gpa1 and rgs1
(JY1287) and expressing plasmid-derived copies of Gpa1 (□), GTPase deficient Gpa1Q244L(▲) and 
both wild type Rgs1 with wild type Gpa1 (■), (D) containing wild type Rgs1 with a single 
chromosomal copy (■) or a chromosomal copy supplemented with a plasmid copy of Gpa1 (●) of 
Gpa1, and the Rgs1 deleted strain containing a chromosomal copy (□) or chromosomal copy 
supplemented with a plasmid copy of Gpa1 (○). Results are means ± S.E.M. of triplicate 
determinations from three independent isolates.
Fig. 2
Deletion of RGS protein has both positive and negative effects on pheromone signaling.
Pheromone-dependent transcription of -galactosidase (OD420/106 cells) expressed from the 
sxa2>lacZ reporter construct was measured at 2 hours intervals from 0-16 hours in strains 
containing (■) wild type Rgs1 or deleted (□) in Rgs1 (Panels A-I). Results are the means ± standard 
error of the mean (S.E.M) of triplicate determinations from three separate isolates.
Fig. 3
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
23
A new reaction scheme describing the regulation of a G protein within a GPCR signaling cascade.
The reaction scheme includes terms for an RGS activity accelerating GTP hydrolysis at two 
separate stages within the sequence (GGTP and ĜGTP). The binding of a ligand (L) to a receptor (R) 
is followed by association with a heterotrimeric G protein (LRG(β)). Dissociation of the complex 
generates GTP bound G-subunit (GGTP), free β-subunits (Gβ) and ligand bound receptor (LR). 
GGTP can either hydrolyze the GTP to form GDP-bound G subunit plus inorganic phosphate 
(GGDP+P) which can be accelerated by interaction with an RGS (via formation of a RGSGGTP) or 
encounter an effector to form the active G*GTPEffector complex [3]. Following effector activation, 
G*GTP enters an inert state (ĜGTP), unable to activate further effectors prior to conversion to 
GGDP+P in a reaction that can be accelerated by RGS activity (RGSĜGTP). GGDP+P reverts to 
GGDP (P tends to ) and can then re-associate with Gβ prior to reactivation by a ligand-bound 
receptor. The colored boxes enclose the key conceptual sections of the model. The red box indicates 
the states in which the G protein is inactive, the green box holds the activated (pre-signaling) state 
and the cyan box holds the inert (post-signaling) state. The orange box contains the pathway 
regulator; in the purple box, the regulator bound to the pre-signaling state and in the dark blue box, 
the regulator bound to the post-signaling state. 
Fig. 4
Computational modeling simulates both positive and negative effects of RGS activity on effector 
output. Reaction parameters for the individual steps (k1-k17) and initial reactant concentrations are 
supplied in the Supplementary table S1, and S2. The concentration of ligand was varied over the 
range 0-100 µM, in simulations of 0-16 hour’s induction (panels A-I) in the presence (▬) or 
absence (▬) of functional RGS activity. RGS activity was removed from the reaction scheme by 
reducing its concentration within the model to 0. Output from the model shows the accumulation of 
G*GTPEffector complexes over the duration of the simulated assay.
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Fig. 5
Computational modeling simulates the properties of both G and G in regulating effector 
activation. The concentration of ligand was varied over the range 0-100 µM following simulation of 
16 hours induction. Output from the model shows the accumulation of G*GTPEffector complexes 
over the duration of the simulated assay. (A) Simulations were in the presence (▬) or absence (▬) 
of functional RGS activity or an RGS insensitive G subunit (GRGSi, ▬) equivalent to GG223S. 
The model output is equivalent in the absence of RGS or when RGS is unable to interact with G. 
(B) Simulations in the presence of a GTPase defective and therefore constitutively active form of 
G (G-GTPase, ▬) equivalent to GQ244L plus an active RGS species. Data for wild type G (▬) 
and (GRGSi, ▬) are included for comparison. (C) Simulations in the presence of a GTPase 
defective and therefore constitutively active form of G (G-GTPase, ▬) in the absence of an RGS 
species. Data for wild type G (▬) or wild type G plus RGS (▬) are included for comparison. (D) 
Simulations in the presence of an RGS activity with 1x (▬) or 2x – –G or in the absence of an 
RGS activity with 1x (▬) or 2x – –GEffector output from simulations in which the signal 
propagator function was converted from GGTP to G in the presence (▬) and absence (▬) of 
functional RGS activity. The effect of rendering the G subunit GTPase deficient (G-GTPase, ▬) in 
the presence of an RGS activity was also simulated.
Fig. 6
Using a combination of experimental and computational approaches to investigate the relationship 
between output and concentration of RGS. The concentration of RGS in the model or in the yeast 
was varied over the range 0-3 fold for varying concentrations (0-100 µM) of ligand (model) or 
pheromone (in vivo) following 16 hours induction. (A) Simulations in the presence of 1x (▬), 2x 
(▬) and 3x (▬) RGS or No RGS (▬). Output from the model shows the accumulation of 
G*GTPEffector complexes over the duration of the simulated assay. (B) RGS concentration in the 
yeast was manipulated either by deleting the chromosomal copy (▬) and then introducing 1 
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plasmid copy of Rgs1 (1x, ▬), 2 plasmid copies of Rgs1 (2x, ▬) or 2 plasmid copies with the 
chromosomal copy of Rgs1 (3x, ▬). Output from the in vivo experiments used the pheromone-
dependent transcription of -galactosidase expressed from the sxa2>lacZ reporter construct and are 
means ± S.E.M. of triplicate determinations from three independent isolates. (C) Simulating the 
accumulation of G*GTPEffector complexes over a range of RGS (0-300 nM) and ligand 
concentrations (0-100 µM). (D) Plotting the mean (± S.E.M) -galactosidase expression levels 
against the number of copies of the rgs1 gene expressed within the yeast. (C) and (D) demonstrate 
that the relationship between response and concentration of RGS, both in the model and in vivo, is 
non-monotone. 
Fig. 7
A dynamic motif for G protein signaling. Abstraction of the reaction scheme shown in Fig. 3 (in 
terms of the sections represented by the colored boxes), generates a simple network motif (A). X 
can attain three states, X°, the basal unstimulated state (compare with GGDP), X[1], a pre-signaling 
state (compare with GGTP), and X[2], a post-signaling state (compare with ĜGTP). The free 
regulatory molecule, R° (compare with the RGS protein), can bind both states of the signaling 
molecule, leading to R[1] and R[2] respectively, and promotes their return to the basal state, X°, 
simultaneously freeing R°. Transitions between states are controlled by the rate constants 
(). Output occurs when the signaling molecule makes the transition between X[1]
and X[2]. (B) The relationship between maximum output and the quantity of free-regulatory 
molecule, for the motif in A is sufficient to produce the dynamical properties that give rise to the 
non-monotone behavior demonstrated by the in vivo data. (C) Removal of the post-signaling state 
(X[2]) from the motif in A, produces a network motif where the regulatory molecule acts solely as a 
negative regulator of maximal steady state output (D). This network motif depicts the underlying 
structure of many existing G protein GTPase models and hypotheses (see Supplementary text). For 
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both motifs the steady state output flux of the system is the product γX[1], (the rate of transition 
from pre- to post-signaling state) and has been determined when the input is at its maximum.
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